STAT3 and lip and oral cavity carcinoma: This study observed that the STAT3 inhibitor stattic robustly compromised TNF-α-induced upregulation of inflammation-related genes in oral cancer cells (Figure 5), emphasizing the significant role of IL-37 in modulating inflammation in these cells.